- Home
- COR vs MET Comparison
COR vs MET Comparison
Compare COR & MET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COR | MET |
|---|---|---|
| Founded | 2001 | 1863 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.1B | 65.4B |
| IPO Year | 2001 | 1999 |
Fundamental Metrics
Financial Performance| Metric | COR | MET |
|---|---|---|
| Price | $339.53 | $100.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 18 |
| Target Price | ★ $371.67 | $107.63 |
| AVG Volume (30 Days) | 1.2M | ★ 2.9M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | 0.75% | ★ 2.30% |
| EPS Growth | ★ 5.71 | N/A |
| EPS | ★ 15.21 | 2.83 |
| Revenue | ★ $321,332,819,000.00 | $77,084,000,000.00 |
| Revenue This Year | $4.89 | $2.91 |
| Revenue Next Year | $4.35 | $4.33 |
| P/E Ratio | ★ $23.27 | $36.37 |
| Revenue Growth | ★ 9.31 | 8.59 |
| 52 Week Low | $244.82 | $67.33 |
| 52 Week High | $377.54 | $103.65 |
Technical Indicators
Market Signals| Indicator | COR | MET |
|---|---|---|
| Relative Strength Index (RSI) | 71.19 | 61.25 |
| Support Level | $299.24 | $92.95 |
| Resistance Level | $375.91 | $103.65 |
| Average True Range (ATR) | 7.60 | 1.97 |
| MACD | 1.04 | 0.03 |
| Stochastic Oscillator | 95.39 | 87.31 |
Price Performance
Historical ComparisonAbout COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
About MET MetLife Inc.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.